Health promotion in persons with schizophrenia: atypical medications |
| |
| Affiliation: | 1. CeNDEF, Amsterdam School of Economics, Universiteit van Amsterdam, Roetersstraat 11, 1018 WB Amsterdam, the Netherlands;2. Paris School of Economics, Université Paris 1 Panthéon-Sorbonne, 48 boulevard Jourdan, 75014 Paris, France;3. Tinbergen Institute, Gustav Mahlerplein 117, 1082 MS Amsterdam, the Netherlands;2. Department of Psychiatric Social Work, Institute of Mental Health, Pt. B.D Sharma University of Health Sciences, Rohtak 124001, India |
| |
| Abstract: | Nearly 2 million Americans suffer from schizophrenia, which is considered the most chronic and disabling of the severe mental disorders. In addition to psychotic symptoms, cognitive deficits, and social impairments, persons with schizophrenia are faced with multiple barriers to the achievement of optimal health. Psychiatric nurses must assess physical and psychological risk factors, monitor medication responses and side effects, and provide health promotion strategies for persons with schizophrenia. After providing a brief summary of the diagnostic criteria and clinical features of schizophrenia, this article reviews medication management with atypical agents and serious drug reactions. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
